Biotech
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 02/02/16 -- (NASDAQ: CBLI) today announced the initiation of a Phase 2, single-blind, randomized, placebo-controlled clinical study of the safety and tolerability of ...
WILMINGTON, DE: WILMINGTON, DE -- (Marketwired) -- 02/02/16 -- NeuroRx, Inc., a clinical stage pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders, today announ ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 02/01/16 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR) held its 2016 Annual General and Special Meeting of Shareholders on January 29, 2016. Incumbent Director ...
NORWOOD, MA: Presentation With Live Webcast on Tuesday, February 9 at 8:30 a.m. EST ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/29/16 -- SciVac Therapeutics Inc. ("SciVac" or the "Company") (TSX: VAC)(OTCQX: SVACF) is pleased to announce that SciVac recei ...
SUGAR LAND, TX: SUGAR LAND, TX -- (Marketwired) -- 01/29/16 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the global economic headache spirals into a migraine, the pharmaceutica ...
CLAREMONT, CA: CLAREMONT, CA -- (Marketwired) -- 01/28/16 -- Kiwa Bio-Tech Products Group Corporation (OTC PINK: KWBT) ("Kiwa" or "the Company") announced that on January 28, 2016 (the "Eff ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 01/27/16 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima", the "Company") announces the granting of patent number US 9,244,059 entitled ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 01/27/16 -- Medivation, Inc. (NASDAQ: MDVN) today announced that David Hung, M.D., founder, president and chief executive officer and Rick Bierly, chief financia ...
TORONTO, ONTARIO: - Proprietary industry-leading fluorine-based medicinal chemistry platform providing an internal engine to generate future programs - Platform validated by several advanced preclinical oncology progra ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 01/26/16 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD), a leading immuno-oncology company, is pleased to announce the initiation of the first clinical trial site ...
DUBLIN, IRELAND: Continues Global Expansion Strategy for Once-Daily, Dual Mechanism Antibiotic for MRSA Infections ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 01/26/16 -- (NASDAQ: CBLI) today announced the start of dosing in a Phase 2, randomized, placebo-controlled clinical study of CBLB612 as myelosuppressive prophylaxis i ...
MONCTON, NEW BRUNSWICK: MONCTON, NEW BRUNSWICK -- (Marketwired) -- 01/26/16 -- Soricimed Biopharma Inc., a private clinical stage company developing novel cancer therapeutics and diagnostics, is pleased to announce that Bo ...
LONDON, ONTARIO: CCRM to establish, optimize and validate methods for producing Sernova's transformative cell-based therapies for Type-1 diabetes ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 01/21/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report preliminary fourth quarter and full year 2015 financial results and prov ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 01/21/16 -- Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM)(OTCQX: HMTXF), a clinical-stage autologous cell-therapy company ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 01/21/16 -- Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:)(OTCQX:), a clinical-stage autologous cell-therapy company, announce ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/19/16 -- Pacgen Life Sciences Corporation, (TSX VENTURE: PBS) ("Pacgen" or the "Company") announced today that it plans to comp ...
